Yan Wei
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
Papers in
-
- Extracellular vesicles in disease 5
- RNA Interference and Gene Delivery 4
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Jiacan Su (9 shared papers)Can Xu (6 shared papers)Shihao Sheng (5 shared papers)Yong Gan (5 shared papers)Xiao Chen (2 shared papers)Fengjin Zhou (5 shared papers)Ke Xu (4 shared papers)Shiyan Guo (3 shared papers)
- Journals
- ACS Nano (3 papers)Acta Pharmaceutica Sinica B (2 papers)International Journal of Pharmaceutics (2 papers)Journal of Nanobiotechnology (2 papers)Advanced Functional Materials (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yan Wei
28 papers receiving 938 citations
Yan Wei's Hit Papers
Peers
Comparison fields: 5 of 98
- Biomaterials 279
- Pharmaceutical Science 47
- Cancer Research 100
- Biomedical Engineering 306
- Molecular Biology 385
Countries citing papers authored by Yan Wei
This map shows the geographic impact of Yan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Wei more than expected).
Fields of papers citing papers by Yan Wei
This network shows the impact of papers produced by Yan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Wei. The network helps show where Yan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases Hit paper breakdown → | 2023 | 143 |
| 2 | 2022 | 78 | |
| 3 | 2017 | 63 | |
| 4 | 2012 | 57 | |
| 5 | 2020 | 56 | |
| 6 | 2022 | 54 | |
| 7 | 2022 | 52 | |
| 8 | 2020 | 47 | |
| 9 | 2013 | 41 | |
| 10 | 2020 | 40 | |
| 11 | 2024 | 38 | |
| 12 | 2024 | 29 | |
| 13 | 2024 | 29 | |
| 14 | 2014 | 28 | |
| 15 | 2020 | 26 | |
| 16 | 2021 | 25 | |
| 17 | 2024 | 25 | |
| 18 | 2023 | 22 | |
| 19 | 2024 | 19 | |
| 20 | 2021 | 17 |
About Yan Wei
Yan Wei is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Rheumatology, having authored 30 papers that have together received 943 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (6 papers), Extracellular vesicles in disease (5 papers), RNA Interference and Gene Delivery (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Protease and Inhibitor Mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Biomaterials (279 citations), Pharmaceutical Science (47 citations), Cancer Research (100 citations), Biomedical Engineering (306 citations) and Molecular Biology (385 citations). Yan Wei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jiacan Su, Can Xu, Shihao Sheng, Yong Gan, Xiao Chen, Fengjin Zhou, Ke Xu, Shiyan Guo, Xinxin Zhang and Yu-Xi Wang. Their work appears in journals such as ACS Nano, Acta Pharmaceutica Sinica B, International Journal of Pharmaceutics, Journal of Nanobiotechnology and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.